NewAmsterdam Pharma
Developing transformative, clinically validated oral therapies for patients with metabolic diseases.
Launch date
Employees
Market cap
AUD2.2b
Enterprise valuation
AUD1.6b (Public information from Sep 2024)
Share price
$15.92 NAMS
Naarden North Holland (HQ)
Authorizing premium user...